Medicine should be taught in high school

skeptigirl said:
Emphasis mine. And while I tried to explain the reasons for this, kelly seems to think it needs a clinical trial or something. It is basic biology. You don't need a clinical trial to understand how eliminating an entire population of organisms vs leaving behind those that were the last to die and thus the most resistant is a greater risk for developing antibiotic resistance.
Yes, I was looking for evidence, not a statement without references.
And then it became a matter of me asking if anyone was sure the target organism was usually eliminated as opposed to returning to a state of colonization. So then I decided to look the answer up myself, and found that quite often, a full course does not, in fact, totally eradicate the target organism.

There are two separate issues and for whatever reason, some people are having a hard time seeing that:
Not me. I think it's all terribly complex, which is what got me wondering about the whole thing in the first place.

Less antibiotics, yes, noble goal, less resistance overall, over time.

But once you commit to treat an infection, then not finishing that course of antibiotics is more likely to leave that pathogen behind with resistance beginning to accumulate.
I'd say there's a third issue of actual relapse of the infection (infection as opposed to recolonization and resulting shedding of resistant organisms asymptomatically). And a fourth issue of resistance in the non-targeted organisms. And blutoski has brought up the most relevant (to my original question) aspect, (which I suppose is a fifth aspect of this whole issue) which is the rate of information exchange at different population concentrations. And there are a few other aspects I'm aware of that complicate things even further, like the rate of information loss with replication compared to exchange between organisms through plasmids.

Anyway, this is interesting.
http://cee.engr.ucdavis.edu/faculty/Wuertz/Publications/Sorensenetal.2005Nat.Rev..pdf

And this made me laugh. :)

http://www.youtube.com/watch?v=O-EdX4MaMFE&mode=related&search=
 
Last edited:
Yes, I was looking for evidence, not a statement without references.
You claim to see the two problems yet you continue to post without 'getting' one of them. So let me take them one per post.

I repeat: "Less antibiotics, yes, noble goal, less resistance overall, over time."

Excuse the double negative but isn't this what you are claiming is being denied? Isn't this what you are claiming you don't see evidence against? Isn't this the thing you are saying isn't disproved in the NIH information page?
 
You claim to see the two problems yet you continue to post without 'getting' one of them. So let me take them one per post.

I repeat: "Less antibiotics, yes, noble goal, less resistance overall, over time."

Excuse the double negative but isn't this what you are claiming is being denied? Isn't this what you are claiming you don't see evidence against? Isn't this the thing you are saying isn't disproved in the NIH information page?

I'm not sure I understand what you're asking.
Do I think the survivors of a longer course will be more likely to be resistant to the drug than the survivors of a shorter course? Yes.
In both the target organism and the nontarget organisms. (when the target organism isn't totally and completely eradicated, in which case the principal no longer applies or matters there.)

But according to what blutoski is saying, that "survival information" won't be passed on so well, because the survivors with that information aren't going to be able to interact with other organisms, because the density has been reduced through the treatment.
 
Last edited:
.....
And then it became a matter of me asking if anyone was sure the target organism was usually eliminated as opposed to returning to a state of colonization. So then I decided to look the answer up myself, and found that quite often, a full course does not, in fact, totally eradicate the target organism.
No, you found one organism, H-flu wasn't eliminated when OM was treated. And antibiotic treatment of OM can't be discussed in 25 words or less so it wasn't a particularly good example which I already said was my fault for using to illustrate a concept.

In addition, the article you cited about H-flu remaining was even less relevant since one doesn't initially treat OM for H-flu unless there is severe disease.

Diagnosis and Management of Acute Otitis Media; 2004; American Academy of Pediatrics
If a decision is made to treat with an antibacterial agent, the clinician should prescribe amoxicillin for most children. (This recommendation is based on randomized, clinical trials with limitations and a preponderance of benefit over risk.)...[Amoxicillin doesn't cover most H-flu]

...In patients who have severe illness (moderate to severe otalgia or fever of 39°C or higher42) and in those for whom additional coverage for ß-lactamase-positive Haemophilus influenzae and Moraxella catarrhalis is desired, therapy should be initiated with high-dose amoxicillin-clavulanate (90 mg/kg per day of amoxicillin component, with 6.4 mg/kg per day of clavulanate in 2 divided doses).76 This dose has sufficient potassium clavulanate to inhibit all ß-lactamase-producing H influenzae and M catarrhalis....



.....I'd say there's a third issue of actual relapse of the infection (infection as opposed to recolonization and resulting shedding of resistant organisms asymptomatically). And a fourth issue of resistance in the non-targeted organisms.
Those are not third and forth issues. Your 'third' issue is the whole point of completing treatment of the targeted organism. Determining the optimal length of treatment would have an outcome measure of 'no relapse'.

It is a separate issue here whether and for how long antibiotics should be prescribed. If you assume the answer is yes and the length of treatment evidence based, then just who is it you are thinking about in your scenario? It only leaves a patient who you can assume is likely to relapse. If you want to argue they may or may not relapse, then you are arguing a different question about whether the recommended length of treatment is correct.

If the prescribed length of treatment is evidence based and is correct, then the outcome to determine that length most definitely includes the percentage of cases which you would see a relapse in. I cited examples of those studies in my posts replying to Ichne.

Once more, the concept you are not getting here and which you keep claiming requires a study is that by not completing a correctly prescribed course of antibiotics it means by definition you are not eliminating the target organisms. Because a correctly prescribed course of antibiotics would be long enough to eliminate the target organisms but not much longer than that. That means if the antibiotics are not completed the infection is likely going to rebound. And that assumption would be based on the studies determining the optimum length of treatment.

From the AAP guideline on treating OM, you will see a complex decision making analysis.
Data from early studies of patients with AOM show that 19% of children with S pneumoniae and 48% with H influenzae cultured on initial tympanocentesis who were not treated with antibacterial agents cleared the bacteria at the time of a second tympanocentesis 2 to 7 days later.92 Estimates are that approximately 75% of children infected with M catarrhalis also experience bacteriologic cure, based on resolution after treatment with an antibacterial agent to which it is not susceptible (amoxicillin).93,94 Only S pneumoniae that are highly resistant to penicillin will not respond to conventional doses of amoxicillin.95 Accordingly, approximately 80% of children with AOM will respond to treatment with high-dose amoxicillin, including many caused by resistant pneumococci.
What this is saying is half of H-flu and 75% of M catarrhalis were cured by the children's immune systems, not the antibiotics. However, 80% of the Strep pneumoniae needed the antibiotic to be cured in 7 days.

So again, leaving the argument aside about whether one should wait a few days and see if the OM resolves on it's own first or treating it at the onset, once you do decide to treat it, you are really treating only the S pneumoniae.

This is common in medical algorithms. Treatment is given without a culture (not always!) based on the odds. Some people might obtain a culture first (for OM it means sticking a needle through the ear drum if it hasn't already ruptured and it is brief but very painful). You could argue the benefit of doing that before prescribing. But once again, it is a different argument, to treat or not.



Your 'fourth' issue is not a separate issue. It is one of the two issues I noted. I addressed in again in my last post. It's a given that organisms not eliminated add to the genetic pool of resistance.
 
I'm not sure I understand what you're asking.
Do I think the survivors of a longer course will be more likely to be resistant to the drug than the survivors of a shorter course? Yes.
In both the target organism and the nontarget organisms. (when the target organism isn't totally and completely eradicated, in which case the principal no longer applies or matters there.)
I'm not asking what you think about resistance in either organism, I'm trying to point out to you that you are not saying anything different by dividing target and non target organisms.

The issue isn't whether or not resistance is greater in surviving organisms exposed to more antibiotic than to less antibiotic. That is a given!!!!!!!!!

The issue is what happens when you do or don't finish off a colony, any colony, targeted or not. You can't help leaving non targeted organisms behind. That is a given!!!!!!!

You are only treating because it is evidence based that you need to treat.

The length of treatment is evidence based using elimination of the pathogen as the treatment outcome. That is typically measured by % of cases relapsing with X treatment days at Y dose. Relapse is typically measured by repeat or follow up cultures but symptoms matter as well in most outcomes.

Given that you needed to treat this infection, and the length of time was optimized to prevent relapse without exceeding that needed, the only scenario option from not finishing a course of antibiotics is one that includes relapse.


And this is what you keep glossing over.





I'll address blutoski's point next.
 
The factors affecting the density will also depend on the forces allowing the reduced colonies to regrow. In the case of a relapsing infection, the bacteria repopulate the site. In that case, now instead of a few mutated bacteria on their way to developing resistance through multiple mutations, you have the majority of the organisms primed to develop resistance. Millions of more chances for resistance to develop.

If the conditions for the bacteria to actively spread or multiply are not so great, then you would have a smaller volume of genetic material in the pool and resistance would be slower spreading to other organisms.
 
skeptigirl said:
No, you found one organism, H-flu wasn't eliminated when OM was treated.
No, I spent a couple of hours reading all kinds of research on eradication vs. reduction or recolonization asymptomatically. The H. influenzae study was just the first one I found.

http://www.journals.uchicago.edu/JID/journal/issues/v191n11/33258/33258.html

Nasopharyngeal carriage of Streptococcus pneumoniae at the completion of successful antibiotic treatment of acute otitis media predisposes
to early clinical recurrence.
At the completion of successful antibiotic treatment, nasopharyngeal aspirate samples were obtained from 494 (93%) of 530 patients,
and 208 (42%) cultures tested positive for S. pneumoniae. Eighty-six (41%) of the 208 patients who had a nasopharyngeal culture positive for
S. pneumoniae at the successful completion of antibiotic treatment (day 10) also had a nasopharyngeal culture positive for S. pneumoniae at
enrollment (day 1)
. Of the 86 S. pneumoniae isolates found, 59 (69%) represented persistence of the initial nasopharyngeal isolate (same serotype),
whereas the other 27 (31%) represented new pneumococcal nasopharyngeal acquisitions.
Table 2 presents the various types of antibiotic
treatment received by the 208 patients who had nasopharyngeal cultures positive for S. pneumoniae at the completion of successful
antibiotic treatment (day 10), compared with the 286 patients who had nasopharyngeal cultures negative for S. pneumoniae at the completion
of successful antibiotic treatment.

This one shows a decrease in colonization, and says antibiotic treatment influences the competitive balance
http://www.ncbi.nlm.nih.gov/sites/e...med.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus



Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae,
nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media.
Prior use of antibiotics is associated with carriage of resistant bacteria. Colonization by Streptococcus pneumoniae,
Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci (NPAHS), and Staphylococcus aureus was evaluated
in children receiving antibiotic therapy for acute otitis media and in untreated, healthy control subjects. Children were
randomly assigned to receive either amoxicillin/clavulanate (90 mg/kg per day) or azithromycin. Swabs were obtained before
initiating therapy and again 2 weeks and 2 months after initiating therapy. We also obtained swabs from control subjects at
the time of enrollment and 2 weeks and 2 months after enrollment. The decrease in the rate of carriage of S. pneumoniae and
H. influenzae at 2 weeks was significant only in the amoxicillin/clavulanate group (P<.001 and P=.005, respectively).
The rate of nasopharyngeal colonization with NPAHS among treated patients increased from 23% to 39% at 2 months (P=.01).
This increase was similar for both treatment groups. These results suggest that the competitive balance between organisms
is altered by antibiotic therapy.

Here's an animal study on azythromycin and clearance:
http://www.journals.uchicago.edu/JID/journal/issues/v190n10/32426/32426.html
Because nasal colonization with S. pneumoniae is thought to be important in the development of disease caused by this bacterium [14],
the effect that azithromycin has on nasopharyngeal carriage of S. pneumoniae serotype 14 was studied. Our experiments showed that azithromycin
inhibited the ability of infected mice to clear nasal colonization by pneumococcus. The reason for this is likely related to the inhibitory
effect that azithromycin has on humoral responses and the possible impairment of opsonization in, and subsequent clearance of bacteria from,
the respiratory tract.

There are a whole spectrum of effects found. Most of the studies I was able to locate were on OM, too. It's the most studied of all the infections it seems when it comes to eradication vs. a return to flora/colonization.

skeptigirl said:
Those are not third and forth issues. Your 'third' issue is the whole point of completing treatment of the targeted organism. Determining the optimal length of treatment would have an outcome measure of 'no relapse'.
You don't think a relapse of "illness" is a different issue from a return to the floral state for the targeted organism?

It is a separate issue here whether and for how long antibiotics should be prescribed. If you assume the answer is yes and the length of treatment evidence based, then just who is it you are thinking about in your scenario? It only leaves a patient who you can assume is likely to relapse. If you want to argue they may or may not relapse, then you are arguing a different question about whether the recommended length of treatment is correct.
"The answer is yes" to what question???
I think the guidelines are probably primarily based on reducing the chance of relapse to as small of a chance as possible...not a length of time where the scales tip at the 50% probability mark.

Once more, the concept you are not getting here and which you keep claiming requires a study is that by not completing a correctly prescribed course of antibiotics it means by definition you are not eliminating the target organisms.
So if the infection was healed, and the person is well, but the organism goes back to flora or isn't totally eradicated, you think the treatment was a total failure? Even thought the person is well again?

What this is saying is half of H-flu and 75% of M catarrhalis were cured by the children's immune systems, not the antibiotics. However, 80% of the Strep pneumoniae needed the antibiotic to be cured in 7 days.

So again, leaving the argument aside about whether one should wait a few days and see if the OM resolves on it's own first or treating it at the onset, once you do decide to treat it, you are really treating only the S pneumoniae.
Are you equating "cured" with "total and complete clearance from not just the ear but also the nose and throat of the organism that was causing the OM "?
 
Last edited:
The length of treatment is evidence based using elimination of the pathogen as the treatment outcome. That is typically measured by % of cases relapsing with X treatment days at Y dose. Relapse is typically measured by repeat or follow up cultures but symptoms matter as well in most outcomes.
If you're still asymptomatically colonized, but "well"...it's considered a relapse?

The wording here:

(from that university of Chicago press link)

At the completion of successful antibiotic treatment, nasopharyngeal aspirate samples were obtained from 494 (93%) of 530 patients,
and 208 (42%) cultures tested positive for S. pneumoniae. Eighty-six (41%) of the 208 patients who had a nasopharyngeal culture positive for
S. pneumoniae at the successful completion of antibiotic treatment (day 10) also had a nasopharyngeal culture positive for S. pneumoniae at
enrollment (day 1)
.

The infection was healed, the kids were well, it was considered a success, but they were still colonized with the s.pneumo that was causing symptoms previously.

skeptigirl said:
Given that you needed to treat this infection, and the length of time was optimized to prevent relapse without exceeding that needed, the only scenario option from not finishing a course of antibiotics is one that includes relapse.


And this is what you keep glossing over.

I guess I thought "getting well" was the goal. Since the bug that made you "sick" doesn't actually always go away after treatment. It often just goes back to "playing nice". Still there in your nose and throat in smaller numbers, not going bonkers and making you sick. Even after antibiotics a lot of the time.

ETA:

And on a somewhat related note, way back in the thread I mentioned that someone asked me what I thought of their doctor telling them to quit taking antibiotics as soon as they felt well. It was strep throat that she had, which as I mentioned to Ich, I was a carrier of as a kid, and no amount of antibiotics could make me totally clear it.
Anyway...this is interesting...

http://www.jimmunol.org/cgi/content/full/171/5/2532?ck=nck

Group A streptococcus (GAS)3 is the causative agent of a wide variety of human diseases, including pharyngitis, impetigo, necrotizing fasciitis,
and sepsis. The organism is known to persist at the pharyngeal mucosa and tonsils, and can be shed in saliva, even following intense antibiotic
therapy
and without overt disease.
Although known as an extracellular pathogen, GAS produces multiple invasins that allow the bacteria to
efficiently enter a variety of cell lines and primary cultures of tonsillar epithelial cells (1, 2, 3). Österlund et al. (4) reported that
tonsils from children with recurrent tonsillitis contained intracellular streptococci and suggested that this secondary lymphoid organ may
be a reservoir for recurrent infections. Occasionally this organism is associated with rapidly progressing sepsis and, more rarely, with
toxic shock when no evident portals of entry have been identified (5, 6). The mechanism by which it breaches mucosal barriers remains undefined.

Turns out it can live in your monocytes! Yikes! Yuck!
I always wondered what was going on with that. I still wonder exactly what happens when you do clear it...why some folks carry it for a long time and some don't, and what finally kick in to create clearance when it eventually happens.
 
Last edited:
No, I spent a couple of hours reading all kinds of research on eradication vs. reduction or recolonization asymptomatically. The H. influenzae study was just the first one I found.

There are a whole spectrum of effects found. Most of the studies I was able to locate were on OM, too. It's the most studied of all the infections it seems when it comes to eradication vs. a return to flora/colonization.
I'm not sure what these articles are supposed to demonstrate in regards to the question of not completing a course of antibiotics causing increased risk of resistance developing.

Nasopharyngeal Carriage of Streptococcus pneumoniae at the Completion of Successful Antibiotic Treatment of Acute Otitis Media Predisposes to Early Clinical Recurrence This article argues for eliminating the NP strep when treating OM. It doesn't argue one should expect not to eliminate carriage. This is just research which adds to the decision of evaluating the outcome when looking at how long and with what should we treat OM.
Our findings showed that clinical recurrence of AOM caused by S. pneumoniae occurs in the vast majority of patients as a result of nasopharyngeal colonization with this pathogen, despite its eradication from the MEF, at the completion of successful antibiotic treatment for the initial episode of AOM. These findings underline the importance of the drug-pathogen interaction in the nasopharynx as well as in the middle ear. We believe that this relationship should be taken into consideration when the true efficacy of an antibiotic drug in the treatment of AOM is established. A drug that fails to reduce nasopharyngeal colonization with S. pneumoniae at the completion of successful antibiotic treatment of AOM will be associated with an increased rate of clinical recurrence of AOM (most instances of which are true bacteriologic relapses) caused by S. pneumoniae.

In conclusion, we have established the etiological role that nasopharyngeal colonization with S. pneumoniae at the completion of a successful antibiotic treatment of AOM plays in subsequent early clinical recurrence of AOM. We therefore believe that the concept of drug efficacy in the treatment of AOM may be broadened to include nasopharyngeal eradication of S. pneumoniae. Although it is likely that other nasopharyngeal pathogens play a role in the clinical recurrence of AOM, this is yet to be established.


The other two articles have interesting information but I see no relationship to stopping a course of antibiotics short of the evidence based standard length of time. Nor do either support the contention NP carriage is always going to occur after treating OM. Again, this just has nothing to do with stopping a course of antibiotics midway.

A lot of bladder infections are with e-coli. When you treat them you don't expect to sterilize the gut as well. But if you stopped treatment before the evidence based time you would be leaving resistant bacteria in the bladder. Yes, with completing treatment you may increase the resistance in the e-coli that might cause the next infection, but stopping treatment is going to assure you leave resistant bacteria in the bladder.


Originally Posted by skeptigirl
Those are not third and forth issues. Your 'third' issue is the whole point of completing treatment of the targeted organism. Determining the optimal length of treatment would have an outcome measure of 'no relapse'.


You don't think a relapse of "illness" is a different issue from a return to the floral state for the targeted organism?
There is no one size fits all answer here. You are looking at complex treatment algorhythms as if there is a single one for everything. It doesn't work that way.

You need the bladder to be cleared of infection unless there is a permanent indwelling catheter or some other medical condition in which case eliminating bacturia is impractical.

You treat some cases of OM (young infant, and cases not resolving on their own) but typically a viral URI precedes the onset. So leaving bacteria in the NP is not always going to be a risk for relapse. But the young kid in daycare is going to have another URI. You may decide to try eliminating NP carriage or you may use other options like tubes. I wouldn't extend treatment to eliminate NP carriage more than once unless it resulted in a long period free of OM. There needs to be more research on that one and on the best way to eliminate NP carriage.

Each situation has many factors to consider. And sometimes treatment outcome is going to include eliminating the bacteria in the NP, sometimes it isn't. The standard is to use the least amount of antibiotic that is required.

Originally Posted by skeptigirl:
It is a separate issue here whether and for how long antibiotics should be prescribed. If you assume the answer is yes and the length of treatment evidence based, then just who is it you are thinking about in your scenario? It only leaves a patient who you can assume is likely to relapse. If you want to argue they may or may not relapse, then you are arguing a different question about whether the recommended length of treatment is correct.


"The answer is yes" to what question???
I think the guidelines are probably primarily based on reducing the chance of relapse to as small of a chance as possible...not a length of time where the scales tip at the 50% probability mark.
You keep saying you understand what I have said, but here you don't.

Question: is there an advantage in stopping a course of antibiotics short of the specified time?
Different question: Should the antibiotic be prescribed?
AND Is the length of the prescription the optimum length?

Are you are arguing the prescriptions are possibly wrong, or are you saying we should study only partially treating infections?

The prescriptions are evidence based and we know what the outcomes are for partially treating. Drug resistance is greater and the outcomes are often worse. Again, this is all evidence based. Obviously the evidence is never complete. Adjustments are made as new evidence comes in. Stopping treatment midway is not a good thing to do. You seem to think you need a study to tell you that. I suggest you change your question to a more logical one, are current treatment courses optimum length? Because that's really the bottom line here. You don't trust standard medical practices. You have indicated that repeatedly and this is a continuation of your usual position.

Originally Posted by skeptigirl:
Once more, the concept you are not getting here and which you keep claiming requires a study is that by not completing a correctly prescribed course of antibiotics it means by definition you are not eliminating the target organisms.


So if the infection was healed, and the person is well, but the organism goes back to flora or isn't totally eradicated, you think the treatment was a total failure? Even thought the person is well again?
No, again find where I said that. There is an end point for whatever you are treating and those endpoints differ. If the study above is showing leaving NP carriage behind is a risk for relapse, you might try making your endpoint elimination of NP carriage in a child having a second or third case of OM. If it turns out that for kids in daycare, there is so much NP carriage it is a waste of time, they just get reinfected from the other kids, you consider ear tubes. It's like I said, there are some complex treatment algorithms. There is no one size fits all.

Originally Posted by skeptigirl:
What this is saying is half of H-flu and 75% of M catarrhalis were cured by the children's immune systems, not the antibiotics. However, 80% of the Strep pneumoniae needed the antibiotic to be cured in 7 days.

So again, leaving the argument aside about whether one should wait a few days and see if the OM resolves on it's own first or treating it at the onset, once you do decide to treat it, you are really treating only the S pneumoniae.


Are you equating "cured" with "total and complete clearance from not just the ear but also the nose and throat of the organism that was causing the OM "?
Complex treatment algorithms, no one size fits all. How old is the kid, are they in daycare, do they have other health problems, do we need to culture, how many relapses in the past, is the parent getting the med into the kid reliably, can the parent handle the upset baby with ear pain, can the parent stay home from work, what is the current standard?
 
If you're still asymptomatically colonized, but "well"...it's considered a relapse?
In the above post there was some misuse of the word relapse. The study about the risk for recurrent OM was really referring to recurrence.

A relapse is a return to the symptomatic state without complete cure in between and a recurrence is a new infection. There are time frames between symptoms which serve to define the two and sometimes a negative culture in between defines the difference. Rarely you actually do genetic mapping to determine a new vs relapse infection.

(from that university of Chicago press link)
At the completion of successful antibiotic treatment, nasopharyngeal aspirate samples were obtained from 494 (93%) of 530 patients, and 208 (42%) cultures tested positive for S. pneumoniae. Eighty-six (41%) of the 208 patients who had a nasopharyngeal culture positive for S. pneumoniae at the successful completion of antibiotic treatment (day 10) also had a nasopharyngeal culture positive for S. pneumoniae at enrollment (day 1).
The infection was healed, the kids were well, it was considered a success, but they were still colonized with the s.pneumo that was causing symptoms previously.
Originally Posted by skeptigirl
Given that you needed to treat this infection, and the length of time was optimized to prevent relapse without exceeding that needed, the only scenario option from not finishing a course of antibiotics is one that includes relapse.

And this is what you keep glossing over.


I guess I thought "getting well" was the goal. Since the bug that made you "sick" doesn't actually always go away after treatment. It often just goes back to "playing nice". Still there in your nose and throat in smaller numbers, not going bonkers and making you sick. Even after antibiotics a lot of the time.
You can't seem to get away from this issue. You can't seem to discuss the results of not completing treatment. Instead you are discussing the problem of drug resistance in the non-targeted organisms.

Go back and reread what I posted about the two issues. The more antibiotic exposure the more drug resistance NO BRAINER!!!!

But, just because it is the same species does not mean it is the targeted organism. One targets e-coli in the bladder, there's plenty of e-coli left in the gut when treatment is complete.

I USED THE EXAMPLE ABOUT ELIMINATING A PATHOGEN OUTSIDE OF THE SITE OF INFECTION (IE IN THE NASOPHARYNX) JUST TO ILLUSTRATE THE POINT OF LEAVING SOME PARTIALLY RESISTANT BACTERIA. I DID NOT USE IT AS AN EXAMPLE OF THE GOAL OF TREATING EVERY SINGLE INFECTION. When are you going to recognize that point? I have now directly pointed that out to you for the third time.

You are hung up on this all because I used an example to illustrate a point, not because it has any relevance to stopping treatment short of the prescribed time.


And on a somewhat related note, way back in the thread I mentioned that someone asked me what I thought of their doctor telling them to quit taking antibiotics as soon as they felt well. It was strep throat that she had, which as I mentioned to Ich, I was a carrier of as a kid, and no amount of antibiotics could make me totally clear it.
Anyway...this is interesting...

http://www.jimmunol.org/cgi/content/.../5/2532?ck=nck

...
Turns out it can live in your monocytes! Yikes! Yuck!
I always wondered what was going on with that. I still wonder exactly what happens when you do clear it...why some folks carry it for a long time and some don't, and what finally kick in to create clearance when it eventually happens.
I cannot comment on your anecdote about the Dr's advice to your friend because I don't know the circumstances. Many doctors give bad advice, it may be the patient misunderstood, it may be she didn't need the drug and the Dr was only placating her so the advice was stop the drug when you are better and sometimes we will say 24 or 48 hours after fever subsides. It all depends on what you are treating.

As to the idea no one could clear your strep, the presence of bacteria is often misinterpreted, screens are not cultures, cultures do not always identify the causative organism, and all strep is by no means the same.
 
skeptigirl said:
Nor do either support the contention NP carriage is always going to occur after treating OM.
And I never said it would. I said there's a whole spectrum of effects to be seen, but a return to carriage is apparently relatively common.

Again, this just has nothing to do with stopping a course of antibiotics midway.
Well, not directly. But it's relevant to the question of whether or not a return to carriage is common as opposed to a full course virtually always eradicating the organism, which is what your whole argument is based on.
(I see your bold and will up you a size)

There is no one size fits all answer here. You are looking at complex treatment algorhythms as if there is a single one for everything. It doesn't work that way
.

Well no *****, Sherlock. That's been my whole point. It's a complex system, with a variety of things happening in a variety of ways which interact with other complex systems.
A lot of bladder infections are with e-coli. When you treat them you don't expect to sterilize the gut as well. But if you stopped treatment before the evidence based time you would be leaving resistant bacteria in the bladder. Yes, with completing treatment you may increase the resistance in the e-coli that might cause the next infection, but stopping treatment is going to assure you leave resistant bacteria in the bladder.

Right. Well, probably. Or maybe. It might clear before you finish the prescription. And even if it doesn't, your body might wipe out the few remaining ones. But I understand that the idea of the treatment is to bring the chances of relapse down as far as possible (within reason).

Question: is there an advantage in stopping a course of antibiotics short of the specified time?
Maybe sometimes. The question is if whatever possible advantages there might be outweigh the increased risks of a relapse with a now more resistant organism.

Different question: Should the antibiotic be prescribed?
AND Is the length of the prescription the optimum length?

Are you are arguing the prescriptions are possibly wrong, or are you saying we should study only partially treating infections?

I was just wondering how all the factors are weighed against each other, and how nutty that doc was for telling that girl to stop taking her antibiotics when she felt better. I don't have any kind of opinion on all this. I was wondering where the evidence is on antibiotic resistance and stopping treatments early. I've repeated the "always finish your antibiotics, coz if you don't, it'll add to the antibiotic resistance problem" mantra a million times myself, and I realised that I'd never actually seen the evidence.
And the more I thought about it, the more I realised how complex it all really was, and began wondering if maybe the doc wasn't just a nut. Maybe he'd thought of something. Who knows?

I suggest you change your question to a more logical one, are current treatment courses optimum length? Because that's really the bottom line here. You don't trust standard medical practices. You have indicated that repeatedly and this is a continuation of your usual position.

Whatever, skeptigirl. I'm not going to engage you in one of your little petty bickering spats.

No, again find where I said that.

Relapse is typically measured by repeat or follow up cultures but symptoms matter as well in most outcomes.

Given that you needed to treat this infection, and the length of time was optimized to prevent relapse without exceeding that needed, the only scenario option from not finishing a course of antibiotics is one that includes relapse.


And this is what you keep glossing over.

And:

Once more, the concept you are not getting here and which you keep claiming requires a study is that by not completing a correctly prescribed course of antibiotics it means by definition you are not eliminating the target organisms.

You've repeatedly said that total elimination is the purpose of completing the course. As though if there are any targeted organisms left behind relapse is likely.


Complex treatment algorithms, no one size fits all. How old is the kid, are they in daycare, do they have other health problems, do we need to culture, how many relapses in the past, is the parent getting the med into the kid reliably, can the parent handle the upset baby with ear pain, can the parent stay home from work, what is the current standard?

So the answer is "sometimes"?
We could have saved a page of arguing if that was your position from the get-go.
 
Skeptigirl said:
In the above post there was some misuse of the word relapse. The study about the risk for recurrent OM was really referring to recurrence.
That makes a lot more sense.
You can't seem to get away from this issue. You can't seem to discuss the results of not completing treatment. Instead you are discussing the problem of drug resistance in the non-targeted organisms.

Yeah, I think there's a "balance" between the two. I wasn't talking about non-targeted organisms there, though.
I don't have a problem discussing the results of not completing treatment, though.
Not completing treatment increases risk of relapse and recurrence, to a degree that's dependent on how prematurely treatment is ended. (among other factors)

Go back and reread what I posted about the two issues. The more antibiotic exposure the more drug resistance NO BRAINER!!!!
Ironically, I'm sort of not even sure that ends up being the way things pan out in the grand scheme of things once density and plasmid stuff is factored in. But in the few organisms left initially, yes.

But, just because it is the same species does not mean it is the targeted organism. One targets e-coli in the bladder, there's plenty of e-coli left in the gut when treatment is complete.
Err...I'd say it's the same targeted organism just in a different location. E.coli doesn't become a different organism when it's in the wrong place, you know?

I USED THE EXAMPLE ABOUT ELIMINATING A PATHOGEN OUTSIDE OF THE SITE OF INFECTION (IE IN THE NASOPHARYNX) JUST TO ILLUSTRATE THE POINT OF LEAVING SOME PARTIALLY RESISTANT BACTERIA. I DID NOT USE IT AS AN EXAMPLE OF THE GOAL OF TREATING EVERY SINGLE INFECTION.
I guess that was an amazing bad example?

(gawd this bolding and caps is silly)

I cannot comment on your anecdote about the Dr's advice to your friend because I don't know the circumstances. Many doctors give bad advice, it may be the patient misunderstood, it may be she didn't need the drug and the Dr was only placating her so the advice was stop the drug when you are better and sometimes we will say 24 or 48 hours after fever subsides. It all depends on what you are treating.

As to the idea no one could clear your strep, the presence of bacteria is often misinterpreted, screens are not cultures, cultures do not always identify the causative organism, and all strep is by no means the same.

Yeah...I asked her to ask him what he was thinking when she went back for follow up. All I could tell her was "I dunno. That's sounds wrong, but who knows?"
But it got me thinking and wondering and I suppose set the stage for this almost entirely pointless discussion.
As far as the strep goes, it was GAS.
 
....So the answer is "sometimes"?
We could have saved a page of arguing if that was your position from the get-go.
Could have, if you had read what I wrote. :rolleyes:

Post # 130
Originally Posted by kellyb
But if you follow through to day 7, most species of bacteria you're colonized with still survive, right?...


...Not all bacteria are killed by the same drugs, doses or time frames.

Post #136
The effects vary. Yes, a full course of antibiotics for one infection will kill some normal bacteria [IE not colonized pathogens] completely. But those bacteria are common and are soon reintroduced. ...

.... Other times there might be some or no affect. For example, a drug readily absorbed and excreted in your urine will not necessarily get to your lower intestine in any significant amounts. ... It might affect some bacteria because the mucus membrane has a blood supply, but the bacteria might still be unaffected for a number of reasons like the pH or mucus surrounding the bacteria.....

post #180
...In addition, while in many cases an infection only ends when the pathogen is eliminated, there are times when the disease process ends but the bacteria, including known pathogens, remain. So taking an incomplete course of antibiotics may make you well while not eliminating the carrier state while a complete course might have eliminated the carrier state....

And post #203
...The issue under discussion is a partial course of antibiotics vs a full course. Nowhere have I said here that taking a full course of antibiotics assured elimination of a carrier state or avoided antibiotic resistance. I said a partial course was more likely to leave behind resistant bacteria. This is what I said
In addition, while in many cases an infection only ends when the pathogen is eliminated, there are times when the disease process ends but the bacteria, including known pathogens, remain. So taking an incomplete course of antibiotics may make you well while not eliminating the carrier state while a complete course might have eliminated the carrier state.
Nowhere does that say carrier states are eliminated every time you complete a full course of antibiotics....

And post #290
...I USED THE EXAMPLE ABOUT ELIMINATING A PATHOGEN OUTSIDE OF THE SITE OF INFECTION (IE IN THE NASOPHARYNX) JUST TO ILLUSTRATE THE POINT OF LEAVING SOME PARTIALLY RESISTANT BACTERIA. I DID NOT USE IT AS AN EXAMPLE OF THE GOAL OF TREATING EVERY SINGLE INFECTION. When are you going to recognize that point? I have now directly pointed that out to you for the third time.

You are hung up on this all because I used an example to illustrate a point, not because it has any relevance to stopping treatment short of the prescribed time.....
Which afterwards you still missed what I said.
....Well, not directly. But it's relevant to the question of whether or not a return to carriage is common as opposed to a full course virtually always eradicating the organism, which is what your whole argument is based on.
And then,
You've repeatedly said that total elimination is the purpose of completing the course. As though if there are any targeted organisms left behind relapse is likely.
What I repeatedly said was the outcome of treatment is to the endpoint determined by evidence based medicine. In some cases that would include eliminating NP carriage and in some cases it wouldn't. It would always include eliminating the active infection. And leaving behind organisms from the active infection is a set up for inducing a relapse with an increasingly drug resistant infection.



Regarding my petty spat and my claim that you don't trust some medicine, this is a typical statement of yours:
Post #158
Those are the situations (the sinus infection, upper respiratory, etc.) where I'm not at this moment convinced the 2 week course is necessarily the way to go to keep bacterial resistance at bay.
If I end up needing antibiotics myself, I'll take the full course. But I've got the idea stuck in my head that it might not be 'the truth' necessarily.
The point isn't as much of a spat as it is pointing out that you have a preconceived notion the practice of medicine is wrong and you know better.

Providers are often wrong including me. And the science is not perfect, it isn't complete, and there are plenty of differences of opinions. But you often condemn some of the most evidence based practices in medicine such as your frequent assumptions that vaccines are not indicated or your claims the evidence does not support some vaccine use. And you present research to support your claims but it is often out of context, misunderstood, or representing something which additional research has overwhelmingly refuted. You went off claiming flu vaccine had no effect based on one study when it took me 10 minutes to find 10 studies showing a beneficial effect.

Well no *****, Sherlock. That's been my whole point. It's a complex system, with a variety of things happening in a variety of ways which interact with other complex systems....
Your "whole point" has been a mix of comprehension about the factors involved.
...Right. Well, probably. Or maybe. It might clear before you finish the prescription. And even if it doesn't, your body might wipe out the few remaining ones. But I understand that the idea of the treatment is to bring the chances of relapse down as far as possible (within reason).
Yes, your body might wipe out the last of the organisms. But that would be accounted for when you determined the length of treatment using research.

What you cite as a complex system is your way of saying the evidence might be wrong. But you claim that not because you have evidence to the contrary, you claim it because you have some hypothesis that someone should look at not finishing courses of antibiotics (as if no one ever had): For example you said:
Maybe sometimes. The question is if whatever possible advantages there might be outweigh the increased risks of a relapse with a now more resistant organism.
Now why would you think you were the first person to consider that? Why would you think with all the reading of medical research that you do that we don't develop antibiotic recommendations by research?
 
...Ironically, I'm sort of not even sure that ends up being the way things pan out in the grand scheme of things once density and plasmid stuff is factored in. But in the few organisms left initially, yes.
You have to develop resistant genes before you can transfer them.

Err...I'd say it's the same targeted organism just in a different location. E.coli doesn't become a different organism when it's in the wrong place, you know?
You aren't targeting E-coli in the gut when you are treating E-coli in the bladder. And I'm the one using the term "targeted" just to explain what I've been talking about. It isn't a term you hear in discussions of antibiotic use and resistance as far as I know.

I guess that was an amazing bad example?
Considering how you responded to it, yes.
 
Erm, back to teaching stuff in classrooms, should my teacher really be telling the students to paint iodine on their feet instead of taking iron supplements for low iron levels? I might have a really bad cold, but this advice seems to be the worst she has given to us yet.

hooray for teachers teaching this awesome medical stuff to students :(
And yeah, remember, she is preparing us to work in hospitals and health clinics.

Didn't anyone raise their hand and ask how that is supposed to work? Or laugh uncontrollably?
 
skeptigirl said:
Could have, if you had read what I wrote.

Post # 130
Originally Posted by skeptigirl
Originally Posted by kellyb
But if you follow through to day 7, most species of bacteria you're colonized with still survive, right?...

...Not all bacteria are killed by the same drugs, doses or time frames.

Ha! I was just re-reading the thread trying to figure out where the wires got crossed, too.

I noticed the same post.

http://www.internationalskeptics.com/forums/showpost.php?p=2865304&postcount=130

kellyb :
But if you follow through to day 7, most species of bacteria you're colonized with still survive, right?

Are they more antibiotic resistant after a 5 day treatment or a 7 day treatment?


skeptigirl:
No, each organism and site of infection affects the effect of any antibiotic course. Not all bacteria are killed
by the same drugs, doses or time frames.

The correct answer is

1) Yes, the ones you're colonized with survive a lot of the time.

2) Yes, it's a "no-brainer", as you later put it.

Now, if your "No" was really a "yes" or a "sometimes"...you really, really need to learn how to communicate in a way that's comprehensible.

The point isn't as much of a spat as it is pointing out that you have a preconceived notion the practice of medicine is wrong and you know better.

It's called "wondering" and "looking for evidence", skeptigirl. I'm figuring out what's going on in spite of you arguing yet not providing a shred of evidence for anything being discussed so far in the whole thread.
(evidence for things no one's even disputed or questioned or anything doesn't count.)

But you often condemn some of the most evidence based practices in medicine such as your frequent assumptions that vaccines are not indicated or your claims the evidence does not support some vaccine use.

I know you don't like this, but when the Cochrane Collaboration delivers scathing words to public health officials and calls for an "urgent re-evaluation of policy"...it's controversial! Sorry!
Heck...they call it "Policy vs. Evidence"
And conclude:
http://www.bmj.com/cgi/content/full/333/7574/912

The large gap between policy and what the data tell us (when rigorously assembled and evaluated) is surprising. The reasons for this situation are not clear and may be complex

Evidence from systematic reviews shows that inactivated vaccines have little or no effect on the effects measured

Reasons for the current gap between policy and evidence are unclear, but given the huge resources involved, a re-evaluation should be urgently undertaken

The optimistic and confident tone of some predictions of viral circulation and of the impact of inactivated vaccines, which are at odds with the evidence, is striking. The reasons are probably complex and may involve "a messy blend of truth conflicts and conflicts of interest making it difficult to separate factual disputes from value disputes"22 or a manifestation of optimism bias (an unwarranted belief in the efficacy of interventions).23

Whatever the reasons, it is a sobering thought that Archie Cochrane's 1972 statement that we should use what has been tested and found to reach its objectives is as revolutionary now as it was then.

And you're going to accuse me of being "out there"?


skeptigirl said:
What you cite as a complex system is your way of saying the evidence might be wrong.
The evidence for what might be wrong?


But you claim that not because you have evidence to the contrary, you claim it because you have some hypothesis that someone should look at not finishing courses of antibiotics (as if no one ever had): For example you said:

Now why would you think you were the first person to consider that?

You asked a question!
You asked:

skeptigirl said:
Question: is there an advantage in stopping a course of antibiotics short of the specified time?

And then when I answer

Maybe sometimes. The question is if whatever possible advantages there might be outweigh the increased risks of a relapse with a now more resistant organism.

You assume that I assume no one else has thought of that? Or that I "have some hypothesis that someone should look at not finishing courses of antibiotics"?

You're just making things up here. This is extremely bizarre.

If your "Question:" wasn't meant to be answered, then what the heck was the point of asking it?
 
Last edited:

ISF - Join now!

Every member here is approved by hand. No bots, no spam, just people who care about evidence and honest debate.

Membership is free!

Create your free account

Back
Top Bottom